These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 23680942)

  • 1. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
    Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
    Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
    Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.
    Zhou W; Dong L; Wang N; Shi JY; Yang JJ; Zuo ZY; Zhou ZQ
    Neuroimmunomodulation; 2014; 21(4):183-8. PubMed ID: 24504086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agmatine potentiates antidepressant and synaptic actions of ketamine: Effects on dendritic arbors and spines architecture and Akt/S6 kinase signaling.
    Freitas AE; Heinrich IA; Moura TM; Fraga DB; Costa AP; Azevedo D; Brocardo PS; Kaster MP; Leal RB; Rodrigues ALS
    Exp Neurol; 2020 Nov; 333():113398. PubMed ID: 32659382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
    Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
    Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-dose combination of ketamine and guanosine counteracts corticosterone-induced depressive-like behavior and hippocampal synaptic impairments via mTORC1 signaling.
    Camargo A; Dalmagro AP; Wolin IAV; Siteneski A; Zeni ALB; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110371. PubMed ID: 34089815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway.
    Camargo A; Dalmagro AP; Delanogare E; Fraga DB; Wolin IAV; Zeni ALB; Brocardo PS; Rodrigues ALS
    Eur Neuropsychopharmacol; 2022 Apr; 57():15-29. PubMed ID: 35008015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects.
    Fogaça MV; Fukumoto K; Franklin T; Liu RJ; Duman CH; Vitolo OV; Duman RS
    Neuropsychopharmacology; 2019 Dec; 44(13):2230-2238. PubMed ID: 31454827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats.
    Zhu WL; Wang SJ; Liu MM; Shi HS; Zhang RX; Liu JF; Ding ZB; Lu L
    J Psychiatry Neurosci; 2013 Sep; 38(5):306-16. PubMed ID: 23611177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effect of ascorbic acid is associated with the modulation of mammalian target of rapamycin pathway.
    Moretti M; Budni J; Freitas AE; Rosa PB; Rodrigues AL
    J Psychiatr Res; 2014 Jan; 48(1):16-24. PubMed ID: 24209999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway.
    Camargo A; Dalmagro AP; Zeni ALB; Rodrigues ALS
    J Affect Disord; 2020 Jun; 271():100-108. PubMed ID: 32479304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.
    Neis VB; Moretti M; Bettio LE; Ribeiro CM; Rosa PB; Gonçalves FM; Lopes MW; Leal RB; Rodrigues AL
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):959-71. PubMed ID: 27061850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
    Ma XC; Dang YH; Jia M; Ma R; Wang F; Wu J; Gao CG; Hashimoto K
    PLoS One; 2013; 8(2):e56053. PubMed ID: 23390559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant actions of ketamine engage cell-specific translation via eIF4E.
    Aguilar-Valles A; De Gregorio D; Matta-Camacho E; Eslamizade MJ; Khlaifia A; Skaleka A; Lopez-Canul M; Torres-Berrio A; Bermudez S; Rurak GM; Simard S; Salmaso N; Gobbi G; Lacaille JC; Sonenberg N
    Nature; 2021 Feb; 590(7845):315-319. PubMed ID: 33328636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prelimbic neuronal nitric oxide synthase inhibition exerts antidepressant-like effects independently of BDNF signalling cascades.
    Pereira VS; Suavinha ACDR; Wegener G; Joca SRL
    Acta Neuropsychiatr; 2019 Jun; 31(3):143-150. PubMed ID: 30890202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
    Costemale-Lacoste JF; Guilloux JP; Gaillard R
    Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.